Compulsory licensing in India and the ‘big pharma’ debate

pills-tablets-2-1524560A patent enshrines not only a bundle of rights given to an innovator or inventor, but also provides them with a timeframe for monopoly as given under the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) regime.

Read the article >>

Category Articles, News | Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *